Newsletter_04-2024_EN

Thomas Maischberger (left) new Corporate Head
of Research and Development at ZETA.
Together with a major customer, ZETA developed a reusable, environmentally
friendly and stable connectivity solution for the transfer of
liquids in the aseptic processing of biopharmaceuticals and foodstuffs.
The road to market readiness:
How Zeta drives innovation
ZETA’s declared mission „Accelerating the process of bringing
drugs to market in order to save lives“ already calls for
innovative approaches. In fact, innovation is deeply rooted
in the core of ZETA’s corporate culture. Driven by curiosity,
enthusiasm, and a spirit of innovation, ZETA experts develop
new products, solutions, and technologies for the pharmaceutical
and biotech industries. A working environment
where all employees have the opportunity to contribute
their expertise is crucial.
equipment components such as reusable sterile connectors for liquid
transfer are also constantly being developed. ZETA is driving
digitalization forward: Smart Engineering Services represent a software
platform based on an integrated engineering toolchain. Integrated
engineering combined with end-to-end digitalization of data
results in the digital twin of the production system, enabling valuable
smart tools, such as the Smart Maintenance Navigator app and paperless
qualification as part of Integrated Digital Testing.
Best Practice Beispiele aus ZETA R&D
Starting from the tangible benefit for the customer
Whether researching new technologies or developing innovative
products, ZETA’s customer-centric approach is always about creating
a specific benefit or added value for the customer. “We work in
an applicationoriented way and usually start with very specific problems,”
explains Thomas Maischberger, who was recently appointed
Corporate Head of Research and Development. “We strive to push
the boundaries of what biotechnological systems can achieve. Our
aim is to translate the promise of new drugs into actual production
facilities or systems, so that these therapeutics can reach the market
and patients as early as possible.”
A key feature of ZETA is its integrated research approach, in
which research and engineering go hand in hand within interdisciplinary
teams. This involves working very closely with customers and
regularly with universities and other research institutions.
Current highlights and research focus areas
ZETA’s innovation map ranges from data science, integrated engineering
approaches and production simulation to issues relating
to the sustainability of production sites. The list of innovative solutions
and products is correspondingly long. An important focus
of research is the characterization and optimization of bioreactors.
Another major topic is magnetic agitator technology, which thanks
to ZETA has made enormous progress in recent years. Innovative
Product development: multi-use sterile connectors
True to the motto “Developing better solutions for the f uture t ogether”,
Z ETA a nd a m ajor c ustomer based in Vienna succeeded
in developing a reusable, environmentally friendly, stable connection
solution for the transfer of liquids during aseptic processing of
biopharmaceuticals and foodstuffs. Simple, quick, and safe to use,
ZETA sterile connectors are particularly suitable for mobile containers.
The connection process can be carried out in the general
production area and does not require any additional technology to
ensure the sterile integrity of the system, for example laminar flow.
Stainless steel connectors and clamps are used to create a dry connection
between two separate fluid pathways.
The system is suitable for all standard pipe and hose dimensions
and has numerous advantages: The mechanical stability, pressure
load tolerance and temperature resistance are high. The components
can be cleaned and autoclaved and their reusability makes
them particularly environmentally friendly. High process reliability is
guaranteed for aseptic applications in all areas – from upstream and
downstream to fill-and-finish.
A hands-on service: ZETA’s research bioreactor
In collaboration with the Styrian biotechnology company Bisy, ZETA
operates a 50L bioreactor equipped with all relevant functions that is
used for internal research and for the implementation of innovations
www.reinraum.de | www.cleanroom-online.com NEWSLETTER | Edition EN 04-2024
page 16/35